PharmAthene (PIP) soars 28% premarket after the Delaware Supreme Court upholds an earlier ruling...
PharmAthene (PIP) soars 28% premarket after the Delaware Supreme Court upholds an earlier ruling against SIGA Technologies (SIGA) for breach of contractual obligation. In related news: SIGA jumps 10% premarket on the same court ruling as the company notes the court reversed an "equitable payment stream" decision. SIGA also says it intends to establish in Chancery Court "that PIP's evidence of expectancy damages is too speculative, contingent, and conjectural to permit an award." (previous)
From other sites
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs